AU4445701A - Multiple human and mouse otoferlin isoforms - Google Patents
Multiple human and mouse otoferlin isoformsInfo
- Publication number
- AU4445701A AU4445701A AU44457/01A AU4445701A AU4445701A AU 4445701 A AU4445701 A AU 4445701A AU 44457/01 A AU44457/01 A AU 44457/01A AU 4445701 A AU4445701 A AU 4445701A AU 4445701 A AU4445701 A AU 4445701A
- Authority
- AU
- Australia
- Prior art keywords
- isoforms
- multiple human
- otoferlin
- mouse
- mouse otoferlin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19173800P | 2000-03-24 | 2000-03-24 | |
US60/191738 | 2000-03-24 | ||
PCT/IB2001/000578 WO2001070972A2 (en) | 2000-03-24 | 2001-03-23 | Multiple human and mouse otoferlin isoforms |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4445701A true AU4445701A (en) | 2001-10-03 |
Family
ID=22706749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44457/01A Withdrawn AU4445701A (en) | 2000-03-24 | 2001-03-23 | Multiple human and mouse otoferlin isoforms |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4445701A (en) |
WO (1) | WO2001070972A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003046224A1 (en) | 2001-11-28 | 2003-06-05 | The General Hospital Corporation | A blood-based assay for dysferlinopathies |
US7491701B2 (en) | 2004-01-27 | 2009-02-17 | Boys Town National Research Hospital | Peptides that bind to HSP90 proteins |
US20190185864A1 (en) * | 2016-08-23 | 2019-06-20 | Akouos, Inc. | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
KR102606810B1 (en) * | 2017-05-05 | 2023-11-27 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | Compositions and methods for expressing autoperlin |
CN107955833B (en) * | 2017-11-20 | 2021-08-24 | 广州市达瑞生物技术股份有限公司 | Heterozygous mutant dry blood spot positive quality control product suitable for deafness mutant gene detection |
EA202091995A1 (en) * | 2018-02-22 | 2021-03-30 | Акуос, Инк. | COMPOSITIONS AND METHODS FOR TREATMENT OF AGE-NON-AGE-RELATED HEARING IN A HUMAN SUBJECT |
EP4114958A1 (en) | 2020-02-21 | 2023-01-11 | Akouos, Inc. | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
-
2001
- 2001-03-23 WO PCT/IB2001/000578 patent/WO2001070972A2/en unknown
- 2001-03-23 AU AU44457/01A patent/AU4445701A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2001070972A2 (en) | 2001-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001253126A1 (en) | (+) naloxone and epinephrine combination therapy | |
AU3620600A (en) | Skin-marking devices and their use | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
AU2710500A (en) | Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease | |
AU2002211717A1 (en) | Stresscopins and their uses | |
AU2001268525A1 (en) | Human kinases | |
AU2001288612A1 (en) | Human kinases | |
AU2001277959A1 (en) | Human kinases | |
AU2001238488A1 (en) | Human kinases | |
AU3472799A (en) | Dermatological formulations and methods | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
AU2292301A (en) | Human kinases | |
AU2002234773A1 (en) | Pharmaceutically effective ginsenosides and their use | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
AU4427201A (en) | Noise-abatement structure and its constituting elements | |
AU4445701A (en) | Multiple human and mouse otoferlin isoforms | |
AU2002227925A1 (en) | Human beta-defensin-3 | |
AU2001270129A1 (en) | Human phosphodiesterases | |
AU2001261375A1 (en) | Human caspase-12 materials and methods | |
AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
AU2002227352A1 (en) | Human kinases | |
AU2001255573A1 (en) | Human kinases | |
AU4432001A (en) | Trityl-type compounds and their use | |
AU2001274309A1 (en) | Phosphoglycan messengers and their medical uses | |
AU2669201A (en) | Taccalonolides and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK13 | Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant |